Home » Topics » BioWorld Science

BioWorld Science
RSS

XR-5000 advances through clinical trials

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

New introduction for Prograf

Sep. 20, 1996

Sandoz licenses transplant patents from Seragen

Sep. 20, 1996

Improved influenza vaccine enters clinical trials

Sep. 20, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...